Changes to doctor payment for in-office drugs
Aug 02, 2018•9 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Changes to how doctors are paid for drugs that are administered in-office could be on the way depending on the outcomes of two recent regulatory proposals from the Centers for Medicare and Medicaid Services. Also today, who are high-need, high-cost patients?, RA seroconversion is not associated with sustained drug-free remission, and a new myeloma frailty index based on biological cage.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast